Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy.

Shiramizu B, Ananworanich J, Chalermchai T, Siangphoe U, Troelstrup D, Shikuma C, De Grutolla V, Sithinamsuwan P, Praihirunkit P, Rattanamanee S, Valcour V; SEARCH 001.1 Study Group.

J Neurovirol. 2012 Feb;18(1):69-73. doi: 10.1007/s13365-011-0068-8. Epub 2011 Dec 30.

PMID:
22207583
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

HIV, antiretroviral therapies, and the brain.

Liner KJ 2nd, Ro MJ, Robertson KR.

Curr HIV/AIDS Rep. 2010 May;7(2):85-91. doi: 10.1007/s11904-010-0042-8. Review.

PMID:
20425562
[PubMed - indexed for MEDLINE]
3.

Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV.

Shikuma CM, Nakamoto B, Shiramizu B, Liang CY, DeGruttola V, Bennett K, Paul R, Kallianpur K, Chow D, Gavegnano C, Hurwitz SJ, Schinazi RF, Valcour VG.

Antivir Ther. 2012;17(7):1233-42. doi: 10.3851/IMP2411. Epub 2012 Sep 28.

PMID:
23018140
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.

Valcour VG, Shiramizu BT, Shikuma CM.

J Leukoc Biol. 2010 Apr;87(4):621-6. doi: 10.1189/jlb.0809571. Epub 2010 Feb 3. Review.

PMID:
20130221
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Dementia and neurocognitive disorders due to HIV-1 infection.

Ances BM, Ellis RJ.

Semin Neurol. 2007 Feb;27(1):86-92. Review.

PMID:
17226745
[PubMed - indexed for MEDLINE]
6.

Pathogenesis of HIV in the central nervous system.

Valcour V, Sithinamsuwan P, Letendre S, Ances B.

Curr HIV/AIDS Rep. 2011 Mar;8(1):54-61. doi: 10.1007/s11904-010-0070-4. Review.

PMID:
21191673
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

HIV-associated dementia.

Major EO, Rausch D, Marra C, Clifford D.

Science. 2000 Apr 21;288(5465):440-2. No abstract available.

PMID:
10798979
[PubMed - indexed for MEDLINE]
8.

HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.

Ances BM, Clifford DB.

Curr Neurol Neurosci Rep. 2008 Nov;8(6):455-61.

PMID:
18957181
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.

PMID:
12563091
[PubMed - indexed for MEDLINE]
10.

Neurodevelopmental/neuroradiologic recovery of a child infected with HIV after treatment with combination antiretroviral therapy using the HIV-specific protease inhibitor ritonavir.

Tepper VJ, Farley JJ, Rothman MI, Houck DL, Davis KF, Collins-Jones TL, Wachtel RC.

Pediatrics. 1998 Mar;101(3):E7.

PMID:
9493492
[PubMed - indexed for MEDLINE]
11.

Brain structural and functional recovery following initiation of combination antiretroviral therapy.

Becker JT, Cuesta P, Fabrizio M, Sudre G, Vergis EN, Douaihy A, Bajo R, Schubert A, Lopez OL, Parkkonen L, Maestu F, Bagic A.

J Neurovirol. 2012 Oct;18(5):423-7. doi: 10.1007/s13365-012-0115-0. Epub 2012 Jun 13.

PMID:
22692914
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Salvage therapy with abacavir and other reverse transcriptase inhibitors for human immunodeficiency-associated encephalopathy.

Saavedra-Lozano J, Ramos JT, Sanz F, Navarro ML, de José MI, Martín-Fontelos P, Mellado MJ, Leal JA, Rodriguez C, Luque I, Madison SJ, Irlbeck D, Lanier ER, Ramilo O.

Pediatr Infect Dis J. 2006 Dec;25(12):1142-52.

PMID:
17133160
[PubMed - indexed for MEDLINE]
13.

Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors.

Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC.

J Neurovirol. 2000 Feb;6(1):84-8.

PMID:
10787000
[PubMed - indexed for MEDLINE]
14.

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Günthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK.

J Virol. 2005 Feb;79(3):1772-88.

PMID:
15650202
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study.

Valcour VG, Shiramizu BT, Sithinamsuwan P, Nidhinandana S, Ratto-Kim S, Ananworanich J, Siangphoe U, Kim JH, de Souza M, Degruttola V, Paul RH, Shikuma CM; Southeast Asia Research Collaboration with the University of Hawaii 001 protocol team.

Neurology. 2009 Mar 17;72(11):992-8. doi: 10.1212/01.wnl.0000344404.12759.83.

PMID:
19289739
[PubMed - indexed for MEDLINE]
Free PMC Article
16.
17.
18.

Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.

Cantres-Rosario Y, Plaud-Valentín M, Gerena Y, Skolasky RL, Wojna V, Meléndez LM.

AIDS. 2013 Jan 28;27(3):347-56. doi: 10.1097/QAD.0b013e32835b3e47.

PMID:
23291538
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

HIV-associated neurological disorders: a guide to pharmacotherapy.

Tan IL, McArthur JC.

CNS Drugs. 2012 Feb 1;26(2):123-34. doi: 10.2165/11597770-000000000-00000. Review.

PMID:
22201342
[PubMed - indexed for MEDLINE]
20.

Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection.

Lentz MR, Degaonkar M, Mohamed MA, Kim H, Conant K, Halpern EF, Sacktor N, Barker PB, Pomper MG.

J Neurovirol. 2010 Oct;16(5):368-76. doi: 10.3109/13550284.2010.513029.

PMID:
20839921
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk